Bertrand Tombal
Urology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium · Cliniques Universitaires de Saint Luc · Cliniques universitaires saint-Luc (Brussels)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bertrand Tombal as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:39 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07782112 · Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)Ente Ospedaliero Cantonale, Bellinzona · not yet recruiting · Prostatic Neoplasms, Biochemical Recurrence, Oligometastatic Prostate Cancer · study chair
- Ph3NCT05974774 · Intermittent Androgen Deprivation Therapy in the Era of AR Pathway InhibitorsEuropean Organisation for Research and Treatment of Cancer - EORTC · recruiting · Prostate Cancer · study chair
- Ph2NCT02972060 · ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate CancerEuropean Organisation for Research and Treatment of Cancer - EORTC · active not recruiting · Prostate Cancer · study chair
- N/ANCT02440802 · Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate CancerCliniques universitaires Saint-Luc- Université Catholique de Louvain · unknown · Prostate Cancer · principal investigator
- Ph3NCT02194842 · Phase III Radium 223 mCRPC-PEACE IIIEuropean Organisation for Research and Treatment of Cancer - EORTC · active not recruiting · Prostate Cancer · study chair
- Ph4NCT01950871 · Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanningAdvanced Medical Diagnostics s.a. · terminated · Prostate Cancer · principal investigator
- Ph2NCT01658527 · TAK-700 in Castration Resistant Prostate CancerEuropean Organisation for Research and Treatment of Cancer - EORTC · withdrawn · Prostate Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:39 UTC. The ranking covers the 200 most relevant of 85 PubMed records, and a shared surname and initials can bring in a namesake. All 85 on PubMed
- Enzalutamide in metastatic prostate cancer before chemotherapy.N Engl J Med · 20142,392 citationsRCR 70.7
- Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.N Engl J Med · 2022870 citationsRCR 65.1
- 728 citationsRCR 53.8
- 701 citationsRCR 21.6
- 631 citationsRCR 17.3
- 536 citationsRCR 20.1
- 420 citationsRCR 16.8
- Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.N Engl J Med · 2020364 citationsRCR 16.0
- 359 citationsRCR 10.8
- 329 citationsRCR 13.5